These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12425201)

  • 1. [Is mild essential hypertension without obvious organ complications and risk factors associated with increased levels of circulating markers of endothelial dysfunction? Effect of ACE inhibitor therapy].
    Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Aschermann M; Horký K
    Vnitr Lek; 2002 Aug; 48(8):718-23. PubMed ID: 12425201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors.
    Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Horký K; Aschermann M
    J Hum Hypertens; 2002 Aug; 16(8):557-62. PubMed ID: 12149661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE-inhibition modulates some endothelial functions in healthy subjects and in normotensive type 1 diabetic patients.
    Schalkwijk CG; Smulders RA; Lambert J; Donker AJ; Stehouwer CD
    Eur J Clin Invest; 2000 Oct; 30(10):853-60. PubMed ID: 11029598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive vascular damage in hypertension is associated with increased levels of circulating P-selectin.
    Verhaar MC; Beutler JJ; Gaillard CA; Koomans HA; Fijnheer R; Rabelink TJ
    J Hypertens; 1998 Jan; 16(1):45-50. PubMed ID: 9533416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-1 and cardiac mass in essential hypertension: comparative effects of captopril, lisinopril and quinapril.
    Díez J; Laviades C
    J Hypertens Suppl; 1994 Jul; 12(4):S31-6. PubMed ID: 7965272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients.
    Pasini AF; Garbin U; Nava MC; Stranieri C; Pellegrini M; Boccioletti V; Luchetta ML; Fabrizzi P; Lo Cascio V; Cominacini L
    Am J Hypertens; 2007 Apr; 20(4):443-50. PubMed ID: 17386354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clustering of endothelial markers of vascular damage in human salt-sensitive hypertension: influence of dietary sodium load and depletion.
    Ferri C; Bellini C; Desideri G; Giuliani E; De Siati L; Cicogna S; Santucci A
    Hypertension; 1998 Nov; 32(5):862-8. PubMed ID: 9822445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet hyperactivity in hypertensive older patients is controlled by lowering blood pressure.
    Riondino S; Pignatelli P; Pulcinelli FM; Lenti L; Di Veroli C; Marigliano V; Gazzaniga PP
    J Am Geriatr Soc; 1999 Aug; 47(8):943-7. PubMed ID: 10443854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for endothelial cell activation/injury in heatstroke.
    Bouchama A; Hammami MM; Haq A; Jackson J; al-Sedairy S
    Crit Care Med; 1996 Jul; 24(7):1173-8. PubMed ID: 8674331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.
    Mancini GB; Henry GC; Macaya C; O'Neill BJ; Pucillo AL; Carere RG; Wargovich TJ; Mudra H; Lüscher TF; Klibaner MI; Haber HE; Uprichard AC; Pepine CJ; Pitt B
    Circulation; 1996 Aug; 94(3):258-65. PubMed ID: 8759064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endothelial dysfunction in salt sensitive hypertension].
    Ferri C; Bellini C; Desideri G; Di Francesco L; De Mattia G; Santucci A
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):971-4. PubMed ID: 8949361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report.
    Lip GY; Blann AD; Zarifis J; Beevers M; Lip PL; Beevers DG
    J Hypertens; 1995 Dec; 13(12 Pt 2):1674-8. PubMed ID: 8903631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Varughese GI; Patel JV; Tomson J; Blann AD; Hughes EA; Lip GY
    J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of flow-mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension: relationship to cardiovascular risk and effects of treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Felmeden DC; Blann AD; Spencer CG; Beevers DG; Lip GY
    Blood Coagul Fibrinolysis; 2003 Jul; 14(5):425-31. PubMed ID: 12851527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. von Willebrand factor and soluble E-selectin in hypertension: influence of treatment and value in predicting the progression of atherosclerosis.
    Blann AD; Waite MA
    Coron Artery Dis; 1996 Feb; 7(2):143-7. PubMed ID: 8813446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
    Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single (investigator)-blind randomised control trial comparing the effects of quinapril and nifedipine on platelet function in patients with mild to moderate hypertension.
    Islim IF; Bareford D; Beevers DG
    Platelets; 2001 Aug; 12(5):274-8. PubMed ID: 11487379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching.
    Larochelle P; Haynes B; Maron N; Dugas S
    Clin Ther; 1994; 16(5):838-53. PubMed ID: 7859244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplified biochemical activation of endothelial function in hypertension associated with moderate to severe renal failure.
    Cottone S; Mulè G; Amato F; Riccobene R; Vadalà A; Lorito MC; Raspanti F; Cerasola G
    J Nephrol; 2002; 15(6):643-8. PubMed ID: 12495277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of the soluble adhesion molecule E-selectin in essential hypertension.
    Blann AD; Tse W; Maxwell SJ; Waite MA
    J Hypertens; 1994 Aug; 12(8):925-8. PubMed ID: 7529277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.